ENTRADA THERAPEUTICS INC. - COMMON STOCK
17.07
04-October-24 14:59:56
15 minutes delayed
Stocks
+0.63
+3.83%
Today's range
16.68 - 17.20
ISIN
N/A
Source
NASDAQ
-
Entrada Therapeutics to Present at Goldman Sachs 44th Annual Global Healthcare Conference
06 Jun 2023 06:00:01 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports First Quarter 2023 Financial Results
10 May 2023 06:00:01 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Appoints Dr. Bernhardt Zeiher to its Board of Directors
04 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to Participate in Guggenheim Genomic Medicines and Rare Disease Conference
29 Mar 2023 06:00:00 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
06 Mar 2023 06:00:01 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to Participate in Cowen 43rd Annual Health Care Conference
27 Feb 2023 06:00:00 By Nasdaq GlobeNewswire
-
09 Feb 2023 06:00:00 By Nasdaq GlobeNewswire
-
09 Jan 2023 06:00:01 By Nasdaq GlobeNewswire
-
19 Dec 2022 15:30:00 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at Evercore ISI 5th Annual HealthCONx Virtual Conference
22 Nov 2022 06:00:00 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports Third Quarter 2022 Financial Results
07 Nov 2022 06:00:01 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference
30 Aug 2022 06:00:00 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports Second Quarter 2022 Financial Results
11 Aug 2022 06:00:02 By Nasdaq GlobeNewswire
-
04 Aug 2022 06:00:03 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer
19 Jul 2022 06:00:00 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at William Blair Biotech Focus Conference
06 Jul 2022 06:00:00 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at Goldman Sachs Global Healthcare Conference
01 Jun 2022 06:00:02 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports First Quarter 2022 Financial Results
12 May 2022 06:00:01 By Nasdaq GlobeNewswire
-
11 May 2022 08:30:00 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at H.C. Wainwright Global Investment Conference
10 May 2022 06:00:03 By Nasdaq GlobeNewswire